Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07160400

1 development in the corpus

NCT07160400

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 11, 2026 · PHASE 1 TRIAL

A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity

ClinicalTrials.gov

Phase 1 registry record with no results posted; describes planned safety and tolerability assessment in healthy volunteers and obese participants with single and multiple ascending doses.

PreliminaryInnovent Biologics Technology Limited (Shanghai R&D Center)IBI3032 tablets NCT07160400

Reported

Planned enrollment80

Study phasePhase 1

Part A follow-up durationBaseline up to Day 15

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support